CDNA CareDx, Inc.

71.92USD-3.39%Mkt Cap: 3.78B USDP/E: 30.35

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap3.78B USD
Enterprise Value3.69B USD
Revenue (TTM)497.40M USD
Gross Profit256.57M USD
Net Income (TTM)-21.35M USD
Revenue/Share9.66 USD
Last Price71.92 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees761
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)30.35
P/E (Forward)45.98
PEG—
EV/EBITDA144.00
EV/Revenue7.42
P/S7.60
P/B8.07
EPS (TTM)2.37 USD
EPS (Forward)1.56 USD
52W Range
14.7275% of range90.87
52W High90.87 USD
52W Low14.72 USD
Profitability
Gross Margin67.55%
Oper. Margin1.57%
EBITDA Margin5.15%
Profit Margin-5.62%
ROE-7.05%
ROA-5.17%
ROIC-16.48%
ROCE-7.75%
Growth
Revenue Growth39.30%
Earnings Growth1066.70%
Cash Flow & Leverage
Operating CF42.03M USD
CapEx (TTM)6.59M USD
FCF Margin26.23%
FCF Yield3.45%
Net Debt-221.48M USD
Net Debt/EBITDA-8.64
Net Debt/FCF-1.70
Balance Sheet
Debt/Equity0.09
Current Ratio2.31
Quick Ratio2.15
Book Value/Sh8.91 USD
Cash/Share4.77 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)94.43 USD
Upside (mean)+31.3%
Target Range90.00 USD – 100.00 USD
90.00+31.3% to mean100.00
# Analysts7
Ownership
Shares Out.52.54M
Float50.80M
Insiders3.10%
Institutions100.28%
Short Interest
Short Ratio4.9d
Short % Float13.93%
Short % Out.13.68%
Shares Short7.19M
Short (prev mo.)6.59M
Technical
SMA 5066.80 (+7.7%)
SMA 20036.97 (+94.5%)
Beta2.49
S&P 52W Chg12.08%
Avg Vol (30d)1.23M
Avg Vol (10d)1.16M
Technical Indicators
RSI (14)46.6
MACD2.0085
MACD Signal3.7128
MACD Hist.-1.7042
BB Upper90.28 USD
BB Middle77.68 USD
BB Lower65.09 USD
BB Width32.43%
ATR (14)4.954 USD
Vol Ratio (20d)0.72x

About CareDx (NASDAQ: CDNA)

›

CareDx (NASDAQ: CDNA) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 761 employees.

The shares were at 71.92 USD on 19 November 2026, up 379.1% over 52 weeks. Its 52-week range is 14.72 USD to 90.87 USD: the price is 20.9% below the high and 388.6% above the low.

At a market capitalisation of 3.78B USD, it trades at 30.3 times trailing earnings and 46.0 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 15% for CDNA.

CareDx reports return on equity of -7.0%, an operating margin of 1.6% and revenue up 39.3% year over year.

It holds more cash than debt, a net cash position of 221.48M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 94.43 USD is 31.3% above the current price. The next earnings report is expected on 24 February 2027.